Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer

被引:0
|
作者
Jimmy Yip Chuen Chow [1 ]
Zhi Jie Li [2 ]
William Ka Kei [3 ]
Chi Hin Cho [4 ]
机构
[1] Department of Medicine, University of California, San Diego, La Jolla, CA 92037, United States
[2] Western Australia Institute for Medicine Research, the University of Western Australia
[3] Institute of Digestive Diseases, the Chinese University of Hong Kong, Hong Kong, China
[4] School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong, China
关键词
Cathelicidin; Gastrointestinal tract; Cancer; Inflammation; Ulcer repair;
D O I
暂无
中图分类号
R735 [消化系肿瘤]; R571 [食管疾病];
学科分类号
1002 ; 100201 ; 100214 ;
摘要
Cathelicidins, are host defense peptides synthesized and stored in circulating leukocytes and numerous types of epithelial tissues in particular the gastrointestinal (GI) tract and skin. They have been known for their antimicrobial activities against a variety of microbes. Recently it was discovered that they have other significant biological functions and produce appealing pharmacological actions against inflammation and cancer in the GI tract through defined mechanisms. Experimental evidence shows that these actions could be tissue and disease specific and concentration dependent. This article reviews some of the physiological functions of cathelicidins and also their therapeutic potential in the treatment of inflammation and cancer and also the delivery system for this peptide as targeted therapy for various disorders in the GI tract both in animals and humans.
引用
收藏
页码:2731 / 2735
页数:5
相关论文
共 50 条
  • [21] The Therapeutic Potential of Targeting Tumor Microenvironment and Modulation of Immunotherapy in Gastrointestinal Cancer
    Sokhangouy, Saeideh khorshid
    Jamialahmadi, Hamid
    Sani, Mahdieh Sadat Mortazavi
    Khalili-Tanha, Ghazaleh
    Rouzbehani, Arian Karimi
    Mahmoudvand, Golnaz
    Goudarzi, Zahra
    Fakouri, Arshia
    Farokhi, Simin
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Nazari, Elham
    Avan, Amir
    CURRENT CANCER DRUG TARGETS, 2024,
  • [22] Formyl peptide receptor 2: a potential therapeutic target for inflammation-related diseases
    Wang, Jiaying
    Miao, Zhishuo
    Gao, Yinhuang
    Xie, Zhizhong
    Liu, Menghua
    Zou, Wei
    PHARMACOLOGICAL REPORTS, 2025,
  • [23] Targeting myocardial inflammation: investigating the therapeutic potential of atrial natriuretic peptide in atrial fibrosis
    Zhu, Nana
    Li, Tianlun
    Bai, Yili
    Sun, Jiao
    Guo, Jianping
    Yuan, Hongtao
    Shan, Zhaoliang
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [24] Therapeutic potential of targeting inflammation
    Hamilton, John A.
    INFLAMMATION RESEARCH, 2013, 62 (07) : 653 - 657
  • [25] Therapeutic potential of targeting inflammation
    John A. Hamilton
    Inflammation Research, 2013, 62 : 653 - 657
  • [26] The therapeutic value of targeting inflammation in gastrointestinal cancers
    Sun, Beicheng
    Karin, Michael
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (07) : 349 - 357
  • [27] The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung
    Tjabringa, GS
    Rabe, KF
    Hiemstra, PS
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (05) : 321 - 327
  • [28] Inflammation and gastrointestinal cancer: An overview
    Marusawa, Hiroyuki
    Jenkins, Brendan John
    CANCER LETTERS, 2014, 345 (02) : 153 - 156
  • [29] Infection, inflammation, and gastrointestinal cancer
    Boland, CR
    Luciani, MG
    Gasche, C
    Goel, A
    GUT, 2005, 54 (09) : 1321 - 1331
  • [30] Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation
    Xin Jin
    Jiuren Tang
    Xiangyu Qiu
    Xiaoya Nie
    Shengming Ou
    Geyan Wu
    Rongxin Zhang
    Jinrong Zhu
    Cell Death Discovery, 10